Abaxis, Inc. to Present at the Canaccord Genuity 37th Annual Growth Conference

UNION CITY, Calif., Aug. 3, 2017 /PRNewswire/ -- Abaxis, Inc. (Nasdaq: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced today that Clint Severson, Chairman and Chief Executive Officer, will present at the Canaccord Genuity 37^th Annual Growth Conference on Wednesday, August 9, 2017 at 4:30 p.m. ET. The conference will be held at InterContinental Hotel in Boston, MA.

About Abaxis

Abaxis, Inc. is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements.  Our mission is to improve the efficiency of care delivery to and the quality of life of patients in the medical and veterinary markets.  We provide leading edge technology, tools and services that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices.  For more information, visit http://www.abaxis.com.

SOURCE Abaxis, Inc.

Related Links

http://www.abaxis.com